GlassScriptPhysician profile
David L Vannix
NPI 1013084979
$14,959.20
in general payments reported to CMS, 2019-2025
12 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.12 · 2020: $34.58 · 2021: $165 · 2022: $222 · 2023: $12K · 2024: $727 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Food and Beverage: $1,011 · Travel and Lodging: $465 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,000.00 |
| Food and Beverage | $1,011.31 |
| Travel and Lodging | $465.09 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,261.42 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Biotissue Holdings INC. | $200.22 | 2025 | |
| Stryker Corporation | $94.80 | 2024 | Spy-Phi System |
| Integra Lifesciences Corporation | $93.97 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ethicon US, LLC | $92.63 | 2019-2021 | |
| Innocoll Pharmaceuticals Limited | $77.70 | 2021 | |
| Bsn Medical INC | $50.81 | 2025 | |
| Livanova USA, INC. | $21.29 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Merck Sharp & Dohme LLC | $18.55 | 2019 | |
| Davol INC. | $17.40 | 2020 | |
| Smith+Nephew, INC. | $16.13 | 2019 | |
| Kci USA, INC. | $14.28 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Vannix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.